Diabetes, Vol 48, Issue 5 1120-1130, Copyright © 1999 by American Diabetes Association

ARTICLES

Endothelin-1 modulates insulin signaling through phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells

ZY Jiang, QL Zhou, A Chatterjee, EP Feener, MG Myers, MF White and GL King
Research Division, Joslin Diabetes Center, Boston, Massachusetts 02215, USA.

Diminished insulin action in the vasculature may contribute to the development of cardiovascular diseases in diabetes. We have studied insulin's effects on the phosphatidylinositol (PI) 3-kinase pathway in arterial smooth muscle cells (SMCs) and its inhibition by endothelin (ET)-1, a potent vasoactive hormone reported to be elevated in insulin resistance and other vascular diseases. ET-1 increased the level of serine phosphorylation of insulin receptor beta subunit but increased both tyrosine and serine phosphorylation of insulin receptor substrate (IRS)-2. Pretreatment of cells with ET-1 (10 nmol/l) inhibited insulin-stimulated PI 3-kinase activity associated with IRS-2 by 50-60% and inhibited the association of p85 subunit of PI 3-kinase to IRS-2. The inhibition of insulin-stimulated PI 3-kinase activity by ET-1 was prevented by BQ-123, a selective ET(A) receptor antagonist, but was not affected by pertussis toxin. Treatment of cells with phorbol 12-myristate 13-acetate, an activator of protein kinase C (PKC), reduced both insulin-stimulated PI 3-kinase activity by 57% and the association of IRS-2 to the p85 subunit of PI 3-kinase by 40%, whereas GF109203X, a specific inhibitor of PKC, partially prevented the inhibitory effect of ET-1 on insulin-induced PI 3-kinase activity. These results suggested that ET-1 could interfere with insulin signaling in SMCs by both PKC-dependent and -independent pathways.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. Y. Chung and J. W. Walker Interaction and Inhibitory Cross-Talk between Endothelin and ErbB Receptors in the Adult Heart Mol. Pharmacol., June 1, 2007; 71(6): 1494 - 1502. [Abstract] [Full Text] [PDF]

				E. Arikawa, R. C.W. Ma, K. Isshiki, I. Luptak, Z. He, Y. Yasuda, Y. Maeno, M. E. Patti, G. C. Weir, R. A. Harris, et al. Effects of Insulin Replacements, Inhibitors of Angiotensin, and PKC{beta}'s Actions to Normalize Cardiac Gene Expression and Fuel Metabolism in Diabetic Rats Diabetes, May 1, 2007; 56(5): 1410 - 1420. [Abstract] [Full Text] [PDF]

				G. Ahlborg, A. Shemyakin, F. Bohm, A. Gonon, and J. Pernow Dual Endothelin Receptor Blockade Acutely Improves Insulin Sensitivity in Obese Patients With Insulin Resistance and Coronary Artery Disease Diabetes Care, March 1, 2007; 30(3): 591 - 596. [Abstract] [Full Text] [PDF]

				A. Lteif, P. Vaishnava, A. D. Baron, and K. J. Mather Endothelin Limits Insulin Action in Obese/Insulin-Resistant Humans Diabetes, March 1, 2007; 56(3): 728 - 734. [Abstract] [Full Text] [PDF]

				P. A. Sarafidis and G. L. Bakris Insulin and Endothelin: An Interplay Contributing to Hypertension Development? J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 379 - 385. [Abstract] [Full Text] [PDF]

				M. A. Carducci and A. Jimeno Targeting bone metastasis in prostate cancer with endothelin receptor antagonists. Clin. Cancer Res., October 15, 2006; 12(20): 6296s - 6300s. [Abstract] [Full Text] [PDF]

				J. Milan, C. Charalambous, R. Elhag, T. C. Chen, W. Li, S. Guan, F. M. Hofman, and R. Zidovetzki Multiple signaling pathways are involved in endothelin-1-induced brain endothelial cell migration Am J Physiol Cell Physiol, July 1, 2006; 291(1): C155 - C164. [Abstract] [Full Text] [PDF]

				J. Nigro, N. Osman, A. M. Dart, and P. J. Little Insulin Resistance and Atherosclerosis Endocr. Rev., May 1, 2006; 27(3): 242 - 259. [Abstract] [Full Text] [PDF]

				J.-a Kim, M. Montagnani, K. K. Koh, and M. J. Quon Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction: Molecular and Pathophysiological Mechanisms Circulation, April 18, 2006; 113(15): 1888 - 1904. [Abstract] [Full Text] [PDF]

				M. B. Marrero, A. K. Banes-Berceli, D. M. Stern, and D. C. Eaton Role of the JAK/STAT signaling pathway in diabetic nephropathy Am J Physiol Renal Physiol, April 1, 2006; 290(4): F762 - F768. [Abstract] [Full Text] [PDF]

				A. B. Strawbridge and J. S. Elmendorf Phosphatidylinositol 4,5-Bisphosphate Reverses Endothelin-1-Induced Insulin Resistance via an Actin-Dependent Mechanism Diabetes, June 1, 2005; 54(6): 1698 - 1705. [Abstract] [Full Text] [PDF]

				E Diamanti-Kandarakis, K Alexandraki, A Protogerou, C Piperi, C Papamichael, A Aessopos, J Lekakis, and M Mavrikakis Metformin administration improves endothelial function in women with polycystic ovary syndrome Eur. J. Endocrinol., May 1, 2005; 152(5): 749 - 756. [Abstract] [Full Text] [PDF]

				G. Fan, L. M. Ballou, and R. Z. Lin Phospholipase C-independent Activation of Glycogen Synthase Kinase-3{beta} and C-terminal Src Kinase by G{alpha}q J. Biol. Chem., December 26, 2003; 278(52): 52432 - 52436. [Abstract] [Full Text] [PDF]

				C. Miele, A. Riboulet, M. A. Maitan, F. Oriente, C. Romano, P. Formisano, J. Giudicelli, F. Beguinot, and E. Van Obberghen Human Glycated Albumin Affects Glucose Metabolism in L6 Skeletal Muscle Cells by Impairing Insulin-induced Insulin Receptor Substrate (IRS) Signaling through a Protein Kinase C{alpha}-mediated Mechanism J. Biol. Chem., November 28, 2003; 278(48): 47376 - 47387. [Abstract] [Full Text] [PDF]

				Y. Li, S. Eitan, J. Wu, C. J. Evans, B. Kieffer, X. Sun, and R. D. Polakiewicz Morphine Induces Desensitization of Insulin Receptor Signaling Mol. Cell. Biol., September 1, 2003; 23(17): 6255 - 6266. [Abstract] [Full Text] [PDF]

				Z. Y. Jiang, Z. He, B. L. King, T. Kuroki, D. M. Opland, K. Suzuma, I. Suzuma, K. Ueki, R. N. Kulkarni, C. R. Kahn, et al. Characterization of Multiple Signaling Pathways of Insulin in the Regulation of Vascular Endothelial Growth Factor Expression in Vascular Cells and Angiogenesis J. Biol. Chem., August 22, 2003; 278(34): 31964 - 31971. [Abstract] [Full Text] [PDF]

				L. M. Ballou, H.-Y. Lin, G. Fan, Y.-P. Jiang, and R. Z. Lin Activated G{alpha}q Inhibits p110{alpha} Phosphatidylinositol 3-Kinase and Akt J. Biol. Chem., June 20, 2003; 278(26): 23472 - 23479. [Abstract] [Full Text] [PDF]

				Z. He, C. Rask-Madsen, and G.L. King Mechanisms of cardiovascular complications in diabetes and potential new pharmacological therapies Eur. Heart J. Suppl., January 1, 2003; 5(suppl_B): B51 - B57. [Abstract] [PDF]

				B. Gonzalez, S. Lamas, and E. M. Melian Cooperation between Low Density Lipoproteins and IGF-I in the Promotion of Mitogenesis in Vascular Smooth Muscle Cells Endocrinology, November 1, 2001; 142(11): 4852 - 4860. [Abstract] [Full Text] [PDF]

				Y. M. Agazie, J. C. Bagot, E. Trickey, S. P. Halenda, and P. A. Wilden Molecular mechanisms of ATP and insulin synergistic stimulation of coronary artery smooth muscle growth Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H795 - H801. [Abstract] [Full Text] [PDF]

				K.-i. Ishibashi, T. Imamura, P. M. Sharma, S. Ugi, and J. M. Olefsky The Acute and Chronic Stimulatory Effects of Endothelin-1 on Glucose Transport Are Mediated by Distinct Pathways in 3T3-L1 Adipocytes Endocrinology, December 1, 2000; 141(12): 4623 - 4628. [Abstract] [Full Text] [PDF]

				T. Imamura, K.-i. Ishibashi, S. Dalle, S. Ugi, and J. M. Olefsky Endothelin-1-induced GLUT4 Translocation Is Mediated via Galpha q/11 Protein and Phosphatidylinositol 3-Kinase in 3T3-L1 Adipocytes J. Biol. Chem., November 19, 1999; 274(47): 33691 - 33695. [Abstract] [Full Text] [PDF]

				Y. Xiong, H. Tanaka, J. A. Richardson, S. C. Williams, C. A. Slaughter, M. Nakamura, J.-L. Chen, and M. Yanagisawa Endothelin-1 Stimulates Leptin Production in Adipocytes J. Biol. Chem., July 20, 2001; 276(30): 28471 - 28477. [Abstract] [Full Text] [PDF]